$310 Million is the total value of Sio Capital Management, LLC's 63 reported holdings in Q3 2019. The portfolio turnover from Q2 2019 to Q3 2019 was - .
| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| JNJ | New | JOHNSON & JOHNSON | $18,593,000 | – | 143,707 | +100.0% | 5.99% | – |
| AGN | New | ALLERGAN PLC | $16,935,000 | – | 100,629 | +100.0% | 5.46% | – |
| PFE | New | PFIZER INC | $10,292,000 | – | 286,450 | +100.0% | 3.32% | – |
| MCK | New | MCKESSON CORP | $8,636,000 | – | 63,190 | +100.0% | 2.78% | – |
| ABC | New | AMERISOURCEBERGEN CORP | $8,488,000 | – | 103,103 | +100.0% | 2.73% | – |
| REGN | New | REGENERON PHARMACEUTICALS INC | $6,873,000 | – | 24,776 | +100.0% | 2.21% | – |
| CVM | New | CEL-SCI CORPput | $6,219,000 | – | 695,600 | +100.0% | 2.00% | – |
| INMD | New | INMODE LTD | $5,794,000 | – | 269,383 | +100.0% | 1.87% | – |
| HALO | New | HALOZYME THERAPEUTICS INC | $4,969,000 | – | 320,373 | +100.0% | 1.60% | – |
| AXSM | New | AXSOME THERAPEUTICS INCcall | $4,837,000 | – | 239,000 | +100.0% | 1.56% | – |
| HSIC | New | HENRY SCHEIN INCput | $4,128,000 | – | 65,000 | +100.0% | 1.33% | – |
| NVO | New | NOVO NORDISK A/Sadr | $4,089,000 | – | 79,100 | +100.0% | 1.32% | – |
| GKOS | New | GLAUKOS CORPput | $3,238,000 | – | 51,800 | +100.0% | 1.04% | – |
| AMRN | New | AMARIN CORPORATION PLCspons adr new | $3,144,000 | – | 207,400 | +100.0% | 1.01% | – |
| XRAY | New | DENTSPLY SIRONA INCput | $2,666,000 | – | 50,000 | +100.0% | 0.86% | – |
| SPPI | New | SPECTRUM PHARMACEUTICALS INCcall | $2,428,000 | – | 292,700 | +100.0% | 0.78% | – |
| ARNA | New | ARENA PHARMACEUTICALS INC | $2,007,000 | – | 43,857 | +100.0% | 0.65% | – |
| PINC | New | PREMIER INCcl a | $1,984,000 | – | 68,597 | +100.0% | 0.64% | – |
| XCUR | New | EXICURE INC | $1,707,000 | – | 674,672 | +100.0% | 0.55% | – |
| DVAX | New | DYNAVAX TECHNOLOGIES CORP | $1,663,000 | – | 465,299 | +100.0% | 0.54% | – |
| XGN | New | EXAGEN INC | $1,317,000 | – | 85,000 | +100.0% | 0.42% | – |
| VAR | New | VARIAN MEDICAL SYSTEMS INCput | $524,000 | – | 4,400 | +100.0% | 0.17% | – |
| OPK | New | OPKO HEALTH INCcall | $262,000 | – | 125,300 | +100.0% | 0.08% | – |
| HTGM | New | HTG MOLECULAR DIAGNOSTICS INC | $199,000 | – | 300,000 | +100.0% | 0.06% | – |
| LXRX | New | LEXICON PHARMACEUTICALS INC | $62,000 | – | 20,667 | +100.0% | 0.02% | – |
Original filings
The following EDGAR filing(s) were analyzed to create this report:
- View 13F-HR filed 2019-11-14
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| VIKING THERAPEUTICS INC | 24 | Q3 2023 | 3.4% |
| UNITED THERAPEUTICS ORD | 23 | Q3 2023 | 8.3% |
| CARDINAL HEALTH ORD | 20 | Q2 2022 | 7.2% |
| SANOFI SA | 19 | Q3 2022 | 9.8% |
| MEDTRONIC PLC | 18 | Q3 2023 | 5.2% |
| CATALYST BIOSCIENCES INC | 18 | Q3 2021 | 17.8% |
| PFENEX ORD | 18 | Q4 2019 | 5.9% |
| AEGLEA BIOTHERAPEUTICS INC | 18 | Q1 2023 | 1.1% |
| HCA HEALTHCARE INC | 17 | Q2 2022 | 5.5% |
| MCKESSON ORD | 17 | Q1 2022 | 6.0% |
View Sio Capital Management, LLC's complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| Modular Medical, Inc. | February 13, 2023 | 1,091,479 | 10.0% |
| Cellectar Biosciences, Inc. | February 10, 2022 | ? | ? |
| CURIS INC | February 10, 2022 | 3,866,645 | 4.2% |
| Salarius Pharmaceuticals, Inc. | February 10, 2022 | 1,354,291 | 3.0% |
| Larimar Therapeutics, Inc. | February 16, 2021 | 188,661 | 1.2% |
| ACHIEVE LIFE SCIENCES, INC. | February 14, 2020 | ? | ? |
| Bionano Genomics, Inc | February 14, 2020 | 1,210,821 | 4.6% |
| Brickell Biotech, Inc. | February 14, 2020 | ? | ? |
| Trillium Therapeutics Inc. | February 14, 2020 | 2,751,186 | 9.8% |
| ZAFGEN, INC. | February 14, 2020 | 2,283,164 | 6.1% |
View Sio Capital Management, LLC's complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-05-15 |
| SC 13G/A | 2024-02-14 |
| SC 13G | 2024-02-14 |
| SC 13G | 2024-02-14 |
| 13F-HR | 2024-02-13 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-12 |
| 13F-HR | 2023-02-13 |
| SC 13G | 2023-02-13 |
View Sio Capital Management, LLC's complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.